The MyoMobile study will explore the UMANA T1 Heart Monitor, a novel real-time remote cardiac monitoring device. MyoMobile is a prospective, randomized study investigating the effect of a personalized mobile health intervention on the physical activity levels in patients with heart failure
Latest news
Blog
27.02.2025
The evolution of centralized appointment booking systems between regional integration and artificial intelligence
Scenario and benefits
Investor
26.02.2025
The Drug Cell Established
A new french alliance to redefine cell therapies
News
25.02.2025
Hematos IIG Certified by the Saudi Food & Drug Authority
The blood supply chain management software has obtained the Medical Device Marketing Authorization (MDMA)
